New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
iAnthus Capital Holdings, Inc.
IAN.CN
Shape
US Flag

CNQ

Unprofitable

EPS improving

Unprofitable

EPS improving

99M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

99M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

0.01CAD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-100%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

73%

Quote Panel

Shape
Updated October 6, 2024
1W 50.00 % 1M -25.00 % 3M -25.00 % 1Y -50.00 %

Key Metrics

Shape
  • Market Cap

    99.40M


  • Shares Outstanding

    6.63B


  • Share in Float

    3.98B


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    0.015


  • Average Volume

    68500


  • Beta

    0.641


  • Range

    0.0-0.055


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.ianthus.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.43x

P/S Ratio

-0.87x

P/B Ratio

-2.5

Debt/Equity

-36.6%

Net Margin

$-0.0

EPS

How IAN.CN compares to sector?

P/E Ratio

Relative Strength

Shape

IAN.CN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.06
vs -0.11

Q2.22

arrow
arrow

N/A

-0.65
vs -0.09

Q3.22

arrow
arrow

N/A

-0.00
vs -0.09

Q4.22

arrow
arrow

N/A

-0.01
vs -0.15

Q1.23

arrow
arrow

N/A

-0.00
vs -0.06

Q2.23

arrow
arrow

N/A

-0.00
vs -0.65

Q3.23

arrow
arrow

N/A

-0.00
vs -0.00

Q4.23

arrow
arrow

N/A

-0.00
vs -0.01

Q1.24

arrow
arrow

N/A

-0.00
vs -0.00

Q2.24

arrow
arrow

N/A

-0.00
vs -0.00

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-17%

42.8M  vs 51.8M

Q2.22

arrow
arrow

-20%

43.5M  vs 54.2M

Q3.22

arrow
arrow

-20%

39.4M  vs 49.3M

Q4.22

arrow
arrow

-21%

37.6M  vs 47.7M

Q1.23

arrow
arrow

-14%

36.8M  vs 42.8M

Q2.23

arrow
arrow

-11%

38.7M  vs 43.5M

Q3.23

arrow
arrow

+9%

42.9M  vs 39.4M

Q4.23

arrow
arrow

+9%

40.9M  vs 37.6M

Q1.24

arrow
arrow

+13%

41.6M  vs 36.8M

Q2.24

arrow
arrow

+11%

43M  vs 38.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-41%

-0.41
vs -5.26

Q4.22

arrow
arrow

-398%

-3.98
vs -0.41

Q1.23

arrow
arrow

+294%

2.94
vs -3.98

Q2.23

arrow
arrow

+81%

0.81
vs 2.94

Q3.23

arrow
arrow

+39%

0.39
vs 0.81

Q4.23

arrow
arrow

+36%

0.36
vs 0.39

Q1.24

arrow
arrow

+19%

0.19
vs 0.36

Q2.24

arrow
arrow

+12%

0.12
vs 0.19

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News